Engineering Natural Killer Cells for Cancer Immunotherapy. - Wikidata - awgldk - TriplyDB

Engineering Natural Killer Cells for Cancer Immunotherapy.

Engineering Natural Killer Cells for Cancer Immunotherapy.

http://www.wikidata.org/entity/Q39408704

about

Natural Killer Cells: Angels and Devils for Immunotherapy.Cancer Prevention and Treatment by Wholistic Nutrition.Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line.Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells.Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering.Natural killer cells as a therapeutic tool for infectious diseases - current status and future perspectives.Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy.Chimeric Antigen Receptors Based on Low Affinity Mutants of FcεRI Re-direct T Cell Specificity to Cells Expressing Membrane IgE Adenosinergic Signaling Alters Natural Killer Cell Functional Responses Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy Natural Killer Cells: Development, Maturation, and Clinical Utilization

P2860

Q41661175-B7DAFD80-B91F-4320-A80C-0DD532C265C0 Q43258142-C2565311-CAE7-4846-9A98-67FA6A928A02 Q45872592-8AB87ABC-AC62-42AD-9DBE-7F93787F2097 Q47099672-18EA924F-0271-40F0-8C12-38D32AF1D563 Q52597550-F78FC316-36FC-4DFA-9F10-5C7F3D97D509 Q52615722-7C930A83-B86D-4834-891F-C2E27C81431B Q54213151-336BCD7B-56F7-48B9-80AD-03BBDC9712BA Q55150815-5E7B60F2-1DFB-41A6-9EFD-767BDC34947B Q58575867-5221947E-9CD3-4BF9-B3FC-9AB7EE4A2855 Q58697979-A86E5F4D-7AD2-4A78-87C3-1CE460EA9E0B Q58764532-F9CD087B-1705-46F5-A506-1C90C4AC914F Q58785734-11C219D3-101B-4A6F-AABE-5C5A63787CCD

P2860

Engineering Natural Killer Cells for Cancer Immunotherapy.

http://www.wikidata.org/entity/Q39408704

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Engineering Natural Killer Cells for Cancer Immunotherapy.

@en

Engineering Natural Killer Cells for Cancer Immunotherapy.

@nl

type

label

Engineering Natural Killer Cells for Cancer Immunotherapy.

@en

Engineering Natural Killer Cells for Cancer Immunotherapy.

@nl

prefLabel

Engineering Natural Killer Cells for Cancer Immunotherapy.

@en

Engineering Natural Killer Cells for Cancer Immunotherapy.

@nl

P1433

Q39408704-C8F608FC-C7E6-45FF-8643-067A9298AE85

P1476

Q39408704-527F49C1-9CEC-4ABB-AE52-47DB3CD188D7

P2093

Q39408704-0C032C62-E0C0-4B8E-9A13-9A260652A4B2

Q39408704-39412198-77E5-4A59-AC4D-D1BBF8603FAA

Q39408704-4EB25A1C-83B8-42BD-ADE0-2A375E7895E8

Q39408704-E3C5EB16-468E-495B-9CEC-ADF3B4B4B20B

P2860

Q39408704-01190DCE-F83C-475A-9948-B3DD96E30CA6

Q39408704-02260E39-4E2A-43E4-88E4-7A8C138734AF

Q39408704-022A0F79-D6AF-4A62-9B47-E49BCAE9C644

Q39408704-039780CA-98CF-4D04-BABF-7BE3DE2B5B81

Q39408704-057BFE51-FAB1-49B3-8B6E-C704A8E0DA93

Q39408704-0BFEAF02-0D17-4BDA-87F1-EE2BF50B8D88

Q39408704-0E790BAA-F5AB-44D4-A9CD-AFBCEAFE0617

Q39408704-0F7A8E79-557A-42E6-9C7C-2E1F9E5F37CC

Q39408704-10E30C76-819C-4874-B0B9-49D5860347E5

Q39408704-1272764E-BEC4-489F-885C-687F8D9292F7

P304

Q39408704-7ED8648F-EC63-4BB3-AC95-04C17C7C019F

P31

Q39408704-128AE4B4-D8BD-43F4-8C2A-5487CF3C938F

P356

Q39408704-B4ACBF5A-4CE9-41D3-AA0B-87F98F02F129

P433

Q39408704-F80702F3-CE88-4A78-8B55-FB73EB826FEC

P478

Q39408704-40F0B478-D68F-47C6-B3D9-13DB9D8994CC

P577

Q39408704-F0B65735-D42E-4363-A6FF-3DBFBBD7D913

P698

Q39408704-23A36AA9-0C5A-4EE7-B3A1-296CDA9B7D80

P921

Q39408704-098326EE-820D-4211-B7F5-38ECCAA9F713

P932

Q39408704-CA1C5F45-12B1-450E-8CC3-07FB4E11C88B

P356

J.YMTHE.2017.06.012

P1433

Molecular Therapy

P1476

Engineering Natural Killer Cells for Cancer Immunotherapy.

@en

P2093

Elizabeth Shpall

http://www.w3.org/2001/XMLSchema#string

Enli Liu

http://www.w3.org/2001/XMLSchema#string

Katayoun Rezvani

http://www.w3.org/2001/XMLSchema#string

Rayne Rouce

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

An activating immunoreceptor complex formed by NKG2D and DAP10

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer

Natural killer cell biology: an update and future directions

Improving the outcome of leukemia by natural killer cell-based immunotherapeutic strategies

Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells

Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptor

Advantages and applications of CAR-expressing natural killer cells

CAR therapy: the CD19 paradigm

P304

1769-1781

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YMTHE.2017.06.012

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28668320

http://www.w3.org/2001/XMLSchema#string

P921

P932

5542803

http://www.w3.org/2001/XMLSchema#string